Search Legislation

Misuse of Drugs Act 1971

 Help about what version

What Version

 Help about advanced features

Advanced Features

Status:

Point in time view as at 01/04/2003.

Changes to legislation:

There are currently no known outstanding effects for the Misuse of Drugs Act 1971, SCHEDULE 2. Help about Changes to Legislation

Close

Changes to Legislation

Revised legislation carried on this site may not be fully up to date. At the current time any known changes or effects made by subsequent legislation have been applied to the text of the legislation you are viewing by the editorial team. Please see ‘Frequently Asked Questions’ for details regarding the timescales for which new effects are identified and recorded on this site.

Section 2.

SCHEDULE 2U.K. Controlled Drugs

Part IU.K. Class A Drugs

1U.K.The following substances and products, namely:—

[F1(a)]

  • Acetorphine.

  • [F2Alfentanil.]

  • Allylprodine.

  • Alphacetylmethadol.

  • Alphameprodine.

  • Alphamethadol.

  • Alphaprodine.

  • Anileridine.

  • Benzethidine.

  • Benzylmorphine (3-benzylmorphine).

  • Betacetylmethadol.

  • Betameprodine.

  • Betamethadol.

  • Betaprodine.

  • Bezitramide.

  • Bufotenine.

  • Cannabinol, except where contained in cannabis or cannabis resin.

  • Cannabinol derivatives.

  • [F3Carfentanil.]

  • Clonitazene.

  • Coca leaf.

  • Cocaine.

  • Desomorphine.

  • Dextromoramide.

  • Diamorphine.

  • Diampromide.

  • Diethylthiambutene.

  • [F4Difenoxin (1-(3-cyano-3,3-diphenylpropyl)-4-phenylpiperidine-4-carboxylic acid).]

  • DihydrocodeinoneO-carboxymethyloxime.

  • Dihydromorphine.

  • Dimenoxadole.

  • Dimepheptanol.

  • Dimethylthiambutene.

  • Dioxaphetyl butyrate.

  • Diphenoxylate.

  • Dipipanone.

  • [F5Drotebanol (3,4-dimethoxy-17-methylmorphinan-6b, 14-diol).]

  • Ecgonine, and any derivative of ecgonine which is convertible to ecgonine or to cocaine.

  • Ethylmethylthiambutene.

  • [F2Eticyclidine.]

  • Etonitazene.

  • Etorphine.

  • Etoxeridine.

  • [F6Etryptamine]

  • Fentanyl.

  • Furethidine.

  • Hydrocodone.

  • Hydromorphinol.

  • Hydromorphone.

  • Hydroxypethidine.

  • Isomethadone.

  • Ketobemidone.

  • Levomethorphan.

  • Levomoramide.

  • Levophenacylmorphan.

  • Levorphanol.

  • [F3Lofentanil]

  • Lysergamide.

  • Lysergide and otherN-alkyl derivatives of lysergamide.

  • Mescaline.

  • Metazocine.

  • Methadone.

  • Methadyl acetate.

  • Methyldesorphine.

  • Methyldihydromorphine (6-methyldihydromorphine).

  • Metopon.

  • Morpheridine.

  • Morphine.

  • Morphine methobromide, morphineN-oxide and other pentavalent nitrogen morphine derivatives.

  • Myrophine.

  • F7. . .

  • Nicomorphine (3,6-dinicotinoylmorphine).

  • Noracymethadol.

  • Norlevorphanol.

  • Normethadone.

  • Normorphine.

  • Norpipanone.

  • Opium, whether raw, prepared or medicinal.

  • Oxycodone.

  • Oxymorphone.

  • Pethidine.

  • Phenadoxone.

  • Phenampromide.

  • Phenazocine.

  • [F8Phencyclidine.]

  • Phenomorphan.

  • Phenoperidine.

  • Piminodine.

  • Piritramide.

  • Poppy-straw and concentrate of poppy-straw.

  • Proheptazine.

  • Properidine (1-methyl-4-phenyl-piperidine-4-carboxylic acid isopropyl ester).

  • Psilocin.

  • Racemethorphan.

  • Racemoramide.

  • Racemorphan.

  • [F2Rolicyclidine.]

  • [F9Sufentanil.]

  • [F2Tenocylidine.]

  • Thebacon.

  • Thebaine.

  • [F9Tilidate.]

  • Trimeperidine.

  • [F104-Bromo-2,5-dimethoxy-a-methylphenethylamine].

  • 4-Cyano-2-dimethylamino-4,4-diphenylbutane.

  • 4-Cyano-1-methyl-4-phenyl-piperidine.

  • N,N-Diethyltryptamine.

  • N,N-Dimethyltryptamine.

  • 2,5-Dimethoxy-a,4-dimethylphenethylamine.

  • [F11N-Hydroxy-tenamphetamine.]

  • 1-Methyl-4-phenylpiperidine-4-carboxylic acid.

  • 2-Methyl-3-morpholino-1, 1-diphenylpropanecarboxylic acid.

  • [F124-Methyl-aminorex]

  • 4-Phenylpiperidine-4-carboxylic acid ethyl ester.

[F13(b)any compound (not being a compound for the time being specified in sub-paragraph (a) above) structurally derived from tryptamine or from a ring-hydroxy tryptamine by substitution at the nitrogen atom of the sidechain with one or more alkyl substituents but no other substituent;

[F14(ba)the following phenethylamine derivatives, namely:—

  • Allyl(a-methyl-3,4-methylenedioxyphenethyl)amine

  • 2-Amino-1-(2,5-dimethoxy-4-methylphenyl)ethanol

  • 2-Amino-1-(3,4-dimethoxyphenyl)ethanol

  • Benzyl(a-methyl-3,4-methylenedioxyphenethyl)amine

  • 4-Bromo-b,2,5-trimethoxyphenethylamine

  • N-(4-sec-Butylthio-2,5-dimethoxyphenethyl)hydroxylamine

  • Cyclopropylmethyl(a-methyl-3,4-methylenedioxyphenethyl)amine

  • 2-(4,7-Dimethoxy-2,3-dihydro-1H-indan-5-yl)ethylamine

  • 2-(4,7-Dimethoxy-2,3-dihydro-1H-indan-5-yl)-1-methylethylamine

  • 2-(2,5-Dimethoxy-4-methylphenyl)cyclopropylamine

  • 2-(1,4-Dimethoxy-2-naphthyl)ethylamine

  • 2-(1,4-Dimethoxy-2-naphthyl)-1-methylethylamine

  • N-(2,5-Dimethoxy-4-propylthiophenethyl)hydroxylamine

  • 2-(1,4-Dimethoxy-5,6,7,8-tetrahydro-2-naphthyl)ethylamine

  • 2-(1,4-Dimethoxy-5,6,7,8-tetrahydro-2-naphthyl)-1-methylethylamine

  • a,a-Dimethyl-3,4-methylenedioxyphenethylamine

  • a,a-Dimethyl-3,4-methylenedioxyphenethyl(methyl)amine

  • Dimethyl(a-methyl-3,4-methylenedioxyphenethyl)amine

  • N-(4-Ethylthio-2,5-dimethoxyphenethyl)hydroxylamine

  • 4-Iodo-2,5-dimethoxy-a-methylphenethyl(dimethyl)amine

  • 2-(1,4-Methano-5,8-dimethoxy-1,2,3,4-tetrahydro-6-naphthyl)ethylamine

  • 2-(1,4-Methano-5,8-dimethoxy-1,2,3,4-tetrahydro-6-naphthyl)-1-methylethylamine

  • 2-(5-Methoxy-2,2-dimethyl-2,3-dihydrobenzo[b]furan-6-yl)-1-methylethylamine

  • 2-Methoxyethyl(a-methyl-3,4-methylenedioxyphenethyl)amine

  • 2-(5-Methoxy-2-methyl-2,3-dihydrobenzo[b]furan-6-yl)-1-methylethylamine

  • b-Methoxy-3,4-methylenedioxyphenethylamine

  • 1-(3,4-Methylenedioxybenzyl)butyl(ethyl)amine

  • 1-(3,4-Methylenedioxybenzyl)butyl(methyl)amine

  • 2-(a-Methyl-3,4-methylenedioxyphenethylamino)ethanol

  • a-Methyl-3,4-methylenedioxyphenethyl(prop-2-ynyl)amine

  • N-Methyl-N-(a-methyl-3,4-methylenedioxyphenethyl)hydroxylamine

  • O-Methyl-N-(a-methyl-3,4-methylenedioxyphenethyl)hydroxylamine

  • a-Methyl-4-(methylthio)phenethylamine

  • b,3,4,5-Tetramethoxyphenethylamine

  • b,2,5-Trimethoxy-4-methylphenethylamine;]

(c)any compound (not being methoxyphenamine or a compound for the time being specified in sub-paragraph (a) above) structurally derived from phenethylamine anN-alkylphenethylamine,a-methylphenethylamine, anN-alkyl-a-methylphenethylamine,a-ethylphenethylamine, or anN-alkyl-a-ethylphenethylamine by substitution in the ring to any extent with alkyl, alkoxy, alkylenedioxy or halide substituents, whether or not further substituted in the ring by one or more other univalent substituents.]

[F15(d)any compound (not being a compound for the time being specified in sub-paragraph (a) above) structurally derived from fentanyl by modification in any of the following ways, that is to say,

(i)by replacement of the phenyl portion of the phenethyl group by any heteromonocycle whether or not further substituted in the heterocycle;

(ii)by substitution in the phenethyl group with alkyl, alkenyl, alkoxy, hydroxy, halogeno, haloalkyl, amino or nitro groups;

(iii)by substitution in the piperidine ring with alkyl or alkenyl groups;

(iv)by substitution in the aniline ring with alkyl, alkoxy, alkylenedioxy, halogeno or haloalkyl groups;

(v)by substitution at the 4-position of the piperidine ring with any alkoxycarbonyl or alkoxyalkyl or acyloxy group;

(vi)by replacement of the N-propionyl group by another acyl group;

(e)any compound (not being a compound for the time being specified in sub-paragraph (a) above) structurally derived from pethidine by modification in any of the following ways, that is to say,

(i)by replacement of the 1-methyl group by an acyl, alkyl whether or not unsaturated, benzyl or phenethyl group, whether or not further substituted;

(ii)by substitution in the piperidine ring with alkyl or alkenyl groups or with a propano bridge, whether or not further substituted;

(iii)by substitution in the 4-phenyl ring wiith alkyl, alkoxy, aryloxy, halogeno or haloalkyl groups;

(iv)by replacement of the 4-ethoxycarbonyl by any other alkoxycarbonyl or any alkoxyalkyl or acyloxy group;

(v)by formation of an N-oxide or of a quaternary base.]

Textual Amendments

F1"(a)" inserted by S.I. 1977/1243, art. 3(a)

F2Word inserted by S.I. 1984/859, art. 2(2)

F3Word inserted by S.I. 1986/2230, art. 2(2)(a)

F4Word inserted by S.I. 1975/421, art. 3

F5Word inserted by S.I. 1973/771, art. 2

F6Word in Sch. 2 Pt. I para. 1(a) inserted (1.5.1998) by S.I. 1998/750, art. 2(2)

F7Words repealed by S.I. 1973/771, art. 2

F8Word inserted by S.I. 1979/299, art. 2

F9Word inserted by S.I. 1983/765, art. 2(a)

F10Words inserted by S.I. 1975/421, art. 3

F13Sch. 2 Pt. I para. 1(b)(c) added by S.I. 1977/1243, art. 3(b)

F15Sch. 2 Pt. I para. 1(d)(e) added by S.I. 1986/2230, art. 2(2)(b)

2U.K.Any stereoisomeric form of a substance for the time being specified in paragraph 1 above not being dextromethorphan or dextrorphan.

3U.K.Any ester or ether of a substance for the time being specified in paragraph 1 or 2 above [F16not being a substance for the time being specified in Part II of this Schedule].

Textual Amendments

F16Words inserted by S.I. 1973/771, art. 2

4U.K.Any salt of a substance for the time being specified in any of paragraphs 1 to 3 above.

5U.K.Any preparation or other product containing a substance or product for the time being specified in any of paragraphs 1 to 4 above.

6U.K.Any preparation designed for administration by injection which includes a substance or product for the time being specified in any of paragraphs 1 to 3 of Part II of this Schedule.

Part IIU.K. Class B Drugs

1U.K.The following substances and products, namely:—

[F17F18(a)]

  • Acetyldihydrocodeine.

  • Amphetamine.

  • Cannabis and cannabis resin.

  • Codeine.

  • F19. . .

  • Dihydrocodeine.

  • Ethylmorphine (3-ethylmorphine).

  • [F20Glutethimide.]

  • [F20Lefetamine.]

  • [F21Mecloqualone.]

  • [F21Methaqualone.]

  • [F22Methcathinone]

  • Methylamphetamine.

  • [F23a-Methylphenethylhydroxylamine]

  • Methylphenidate.

  • [F21Methylphenobarbitone.]

  • Nicocodine.

  • [F24Nicodicodine (6-nicotinoyldihydrocodeine).]

  • Norcodeine.

  • [F25Pentazocine.]

  • Phenmetrazine.

  • Pholcodine.

  • [F26Propiram.]

  • [F22Zipeprol]

[F17(b)any 5,5 disubstituted barbituric acid.]

Textual Amendments

F17Sch. 2 Pt. 2 para. 1(b) added by S.I. 1984/859, art. 2(3)

F18"(a)" inserted by S.I. 1984/859, art. 2

F21Word inserted by S.I. 1984/859, art. 2(3)

F22Words in Sch. 2 Pt. 2 para. 1(a) inserted (1.5.1998) by S.I. 1998/750, art. 2(3)

F23Word in Sch. 2 Pt. 2 para. 1(a) inserted (1.2.2002) by S.I. 2001/3932, art. 2(3)

F24Words inserted by S.I. 1973/771, art. 2

F26Word inserted by S.I. 1973/771, art. 2

2U.K.Any stereoisomeric form of a substance for the time being specified in paragraph 1 of this Part of this Schedule.

3U.K.Any salt of a substance for the time being specified in paragraph 1 or 2 of this Part of this Schedule.

4U.K.Any preparation or other product containing a substance or product for the time being specified in any of paragraphs 1 to 3 of this Part of this Schedule, not being a preparation falling within paragraph 6 of Part I of this Schedule.

Part IIIU.K. Class C Drugs

1U.K.The following substances, namely:—

  • [F28Alprazolam.]

  • [F29Aminorex]

  • Benzphetamine.

  • [F28Bromazepam.]

  • [F29Brotizolam]

  • [F30Buprenorphine]

  • [F28Camazepam.]

  • [F31Cathine.]

  • [F31Cathinone.]

  • [F28Chlordiazepoxide.]

  • Chlorphentermine.

  • [F28Clobazam.]

  • [F28Clorazepic acid.]

  • [F28Clonazepam.]

  • [F28Clotiazepam.]

  • [F28Cloxazolam.]

  • [F28Delorazepam.]

  • [F32Dextropropoxyphene.]

  • [F28Diazepam.]

  • [F33Diethylpropion.]

  • [F28Estazolam.]

  • [F28Ethchlorvynol.]

  • [F28Ethinamate.]

  • [F28Ethyl loflazepate.]

  • [F31Fencamfamin.]

  • [F31Fenethylline.]

  • [F31Fenproporex.]

  • [F28Fludiazepam.]

  • [F28Flunitrazepam.]

  • [F28Flurazepam.]

  • [F28Halazepam.]

  • [F28Haloxazolam.]

  • [F28Ketazolam.]

  • [F28Loprazolam.]

  • [F28Lorazepam.]

  • [F28Lormetazepam.]

  • [F28Mazindol.]

  • [F28Medazepam.]

  • [F31Mefenorex.]

  • F34. . .

  • Mephentermine.

  • [F28Meprobamate.]

  • [F29Mesocarb]

  • F35. . .

  • [F28Methyprylone.]

  • [F36Midazolam.]

  • [F28Nimetazepam.]

  • [F28Nitrazepam.]

  • [F28Nordazepam.]

  • [F28Oxazepam.]

  • [F28Oxazolam.]

  • [F37Pemoline.]

  • F34. . .

  • Phendimetrazine.

  • [F28Phentermine.]

  • [F28Pinazepam.]

  • F34. . .

  • Pipradrol.

  • [F28Prazepam.]

  • F34. . .

  • F38. . .

  • [F31Pyrovalerone.]

  • [F28Temazepam.]

  • [F28Tetrazepam.]

  • [F28Triazolam.]

  • [F31N-Ethylamphetamine.]

  • [F39(b)Atamestane.

  • Bolandiol.

  • Bolasterone.

  • Bolazine.

  • Boldenone.

  • Bolenol.

  • Bolmantalate.

  • Calusterone.

  • 4-Chloromethandienone.

  • Clostebol.

  • Drostanolone.

  • Enestebol.

  • Epitiostanol.

  • Ethyloestrenol.

  • Fluoxymesterone.

  • Formebolone.

  • Furazabol.

  • Mebolazine.

  • Mepitiostane.

  • Mesabolone.

  • Mestanolone.

  • Mesterolone.

  • Methandienone.

  • Methandriol.

  • Methenolone.

  • Methyltestosterone.

  • Metribolone.

  • Mibolerone.

  • Nandrolone.

  • Norboletone.

  • Norclostebol.

  • Norethandrolone.

  • Ovandrotone.

  • Oxabolone.

  • Oxandrolone.

  • Oxymesterone.

  • Oxymetholone.

  • Prasterone.

  • Propetandrol.

  • Quinbolone.

  • Roxibolone.

  • Silandrone.

  • Stanolone.

  • Stanozolol.

  • Stenbolone.

  • Testosterone.

  • Thiomesterone.

  • Trenbolone.

(c)any compound (not being Trilostane or a compound for the time being specified in sub-paragraph (b) above) structurally derived from 17-hydroxyandrostan-3-one or from 17-hydroxyestran-3-one by modification in any of the following ways, that is to say,

(i)by further substitution at position 17 by a methyl or ethyl group;

(ii)by substitution to any extent at one or more of positions 1, 2, 4, 6, 7, 9, 11 or 16, but at no other position;

(iii)by unsaturation in the carbocyclic ring system to any extent, provided that there are no more than two ethylenic bonds in any one carbocyclic ring;

(iv)by fusion of ring A with a heterocyclic system;

(d)any substance which is an ester or ether (or, where more than one hydroxyl function is available, both an ester and an ether) of a substance specified in sub-paragraph (b) or described in sub-paragraph (c) above;

  • (e)Chorionic Gonadotrophin (HCG).

  • Clenbuterol.

  • Non-human chorionic gonadotrophin.

  • Somatotropin.

  • Somatrem.

  • Somatropin.]

Textual Amendments

F27"(a)" inserted (1.9.1996) by S.I. 1996/1300, art. 2(2)(a)

F28Word inserted by S.I. 1985/1995, art. 2(3)

F29Words in Sch. 2 Pt. 3 para. 1(a) inserted (1.5.1998) by S.I. 1998/750, art. 2(4)

F30Word inserted by S.I. 1989/1340, art. 2(a)

F31Word inserted by S.I. 1986/2230, art. 2(3)

F32Word inserted by S.I. 1983/765, art. 2(a)

F33Word inserted by S.I. 1984/859, art. 2(4)(a)

F34Words repealed by S.I. 1973/771, art. 2

F35Word repealed by S.I. 1984/859, art. 2(4)(a)

F36Word inserted by S.I. 1990/2589, art. 2(b)

F37Word inserted by S.I. 1989/1340, art. 2(b)

F38Word in Sch. 2 Pt. 3 para.1 omitted (1.9.1995) by virtue of S.I. 1995/1966, art. 2

F39Sch. 2 Pt. 3 para. 1(b)-(e) added (1.9.1996) by S.I. 1996/1300, art. 2(2)(b)

2U.K.Any stereoisomeric form of a substance for the time being specified in paragraph 1 of this Part of this Schedule [F40not being phenylpropanolamine.]

Textual Amendments

3U.K.Any salt of a substance for the time being specified in paragraph 1 or 2 of this Part of this Schedule.

4U.K.Any preparation or other product containing a substance for the time being specified in any of paragraphs 1 to 3 of this Part of this Schedule.

Part IVU.K. Meaning of certain Expressions used in this Schedule

For the purposes of this Schedule the following expressions (which are not among those defined in section 37(1) of this Act) have the meanings hereby assigned to them respectively, that is to say—

  • cannabinol derivatives” means the following substances, except where contained in cannabis or cannabis resin, namely tetrahydro derivatives of cannabinol and 3-alkyl homologues of cannabinol or of its tetrahydro derivatives;

  • coca leaf” means the leaf of any plant of the genusErythroxylonfrom whose leaves cocaine can be extracted either directly or by chemical transformation;

  • concentrate of poppy-straw” means the material produced when poppy-straw has entered into a process for the concentration of its alkaloids;

  • medicinal opium” means raw opium which has undergone the process necessary to adapt it for medicinal use in accordance with the requirements of the British Pharmacopoeia, whether it is in the form of powder or is granulated or is in any other form, and whether it is or is not mixed with neutral substances;

  • opium poppy” means the plant of the speciesPapaver somniferum L;

  • poppy straw” means all parts, except the seeds, of the opium poppy, after mowing;

  • raw opium” includes powdered or granulated opium but does not include medicinal opium.

Back to top

Options/Help

Print Options

Close

Legislation is available in different versions:

Latest Available (revised):The latest available updated version of the legislation incorporating changes made by subsequent legislation and applied by our editorial team. Changes we have not yet applied to the text, can be found in the ‘Changes to Legislation’ area.

Original (As Enacted or Made): The original version of the legislation as it stood when it was enacted or made. No changes have been applied to the text.

Point in Time: This becomes available after navigating to view revised legislation as it stood at a certain point in time via Advanced Features > Show Timeline of Changes or via a point in time advanced search.

Close

See additional information alongside the content

Geographical Extent: Indicates the geographical area that this provision applies to. For further information see ‘Frequently Asked Questions’.

Show Timeline of Changes: See how this legislation has or could change over time. Turning this feature on will show extra navigation options to go to these specific points in time. Return to the latest available version by using the controls above in the What Version box.

Close

Opening Options

Different options to open legislation in order to view more content on screen at once

Close

More Resources

Access essential accompanying documents and information for this legislation item from this tab. Dependent on the legislation item being viewed this may include:

  • the original print PDF of the as enacted version that was used for the print copy
  • lists of changes made by and/or affecting this legislation item
  • confers power and blanket amendment details
  • all formats of all associated documents
  • correction slips
  • links to related legislation and further information resources
Close

Timeline of Changes

This timeline shows the different points in time where a change occurred. The dates will coincide with the earliest date on which the change (e.g an insertion, a repeal or a substitution) that was applied came into force. The first date in the timeline will usually be the earliest date when the provision came into force. In some cases the first date is 01/02/1991 (or for Northern Ireland legislation 01/01/2006). This date is our basedate. No versions before this date are available. For further information see the Editorial Practice Guide and Glossary under Help.

Close

More Resources

Use this menu to access essential accompanying documents and information for this legislation item. Dependent on the legislation item being viewed this may include:

  • the original print PDF of the as enacted version that was used for the print copy
  • correction slips

Click 'View More' or select 'More Resources' tab for additional information including:

  • lists of changes made by and/or affecting this legislation item
  • confers power and blanket amendment details
  • all formats of all associated documents
  • links to related legislation and further information resources